Review



microarray laser scanner  (CapitalBio Corporation)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    CapitalBio Corporation microarray laser scanner
    Chinese health biotech firms interviewed and their product/technology portfolios a
    Microarray Laser Scanner, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dna+microarray+laser+scanner+(dna+microarray+scanner+ba/microarray+scanner/pmc07096943-69-52-51
    Average 90 stars, based on 1 article reviews
    microarray laser scanner - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "Chinese health biotech and the billion-patient market"

    Article Title: Chinese health biotech and the billion-patient market

    Journal: Nature Biotechnology

    doi: 10.1038/nbt0108-37

    Chinese health biotech firms interviewed and their product/technology portfolios a
    Figure Legend Snippet: Chinese health biotech firms interviewed and their product/technology portfolios a

    Techniques Used: Recombinant, Produced, Expressing, Enzyme-linked Immunosorbent Assay, Diagnostic Assay, Sandwich ELISA, Marker, Incubation, Cell Culture, Microarray, Software, Immunoprecipitation, Injection, Functional Assay, Calcium Assay, Clone Assay, Hybridization, Immunohistochemistry, Transgenic Assay, Knock-Out, Sequencing, Real-time Polymerase Chain Reaction, Genetically Modified, Histone Deacetylase Assay, In Vivo, Modification, Plasmid Preparation, Isolation, Mutagenesis, In Situ Hybridization, DNA Sequencing, Animal Model

    Collaborations/partnerships between companies interviewed and foreign entities
    Figure Legend Snippet: Collaborations/partnerships between companies interviewed and foreign entities

    Techniques Used: Expressing, Synthesized, Microarray, Functional Assay, Western Blot, Luminex, Histone Deacetylase Assay, Software

    Related Articles

    Microarray:

    Article Title: Identification EXOSC4 as a novel autoantigen of interstitial lung disease in rheumatoid arthritis.
    Article Snippet: The protein chips were then incubated with 1:400 dilution of Cy3-coupled goat anti-human IgG antibody(Bioss, Beijing, China)and washed three times with PBST. .. The microarrays were scanned using a microarray scanner (CapitalBio, Beijing, China). .. The 96-well plates were coated with 0.1 μg/mL of recombinant EXOSC4 proteins (Proteintech, Wuhan, China), overnight at 4°C, followed by 1 h block with 5% BSA at 37°C.

    Article Title: Chinese health biotech and the billion-patient market
    Article Snippet: Bio-Bridge Science , Exclusive out-license of papillomavirus pseudovirus technology to Loyola University (Chicago).. .. CapitalBio , Joint R&D and commercialization programs in China with Affymetrix (Santa Clara, CA, USA) for gene expression profiling and genotyping services (including the development of an advanced GeneChip-compatible point-of-care system) using Affymetrix's photolithographically synthesized oligonucleotide chip technology. Provided non-exclusive rights to Alpha Innotech (San Leandro, CA, USA) for marketing of CapitalBio's microarray laser scanner. Deal to undertake joint product development, manufacturing in China, technology transfer, services and products mutual representation with BioTools (Madrid). Deal to distribute Becton Dickinson (Franklin Lakes, NJ, USA) products in China. Exclusive rights to distribute certain products from Enzo Biochem (New York), BioMachines (Research Triangle Park, NC, USA), Aviva Systems Biology (San Diego), Macherey-Nagel (Düren, Germany), Advalytix (Brunnthal, Germany) in China. Exclusive rights to MediBic (Tokyo) to market CapitalBio's pharmacogenomic services in Japan. Exclusive rights to distribute certain CapitalBio products given to Greenmate Biotech (Seoul, Korea) in Korea, FK Biotec (Port Alegre, Brazil) in Brazil and VitroLab (Istanbul, Turkey) in Turkey. Nonexclusive distribution rights to certain CapitalBio products provided to TechnoConcept (New Delhi, India) and Viswagen Biotech (Kerala, India) in India and Australian Biosearch (Karrinyup, Australia) in Australia.. .. HD Biosciences , Codevelopment of functional assays for several identified GPCRs and ion channels with Organon. Under a nondisclosure agreement, undertaking assay development and hit-to-lead solution for GPCR and kinase targets with two major Western pharmaceutical companies. Cooperation agreement to develop GPCR screening models with Novasite Pharmaceuticals (San Diego)..

    Article Title: WDR73 Depletion Destabilizes PIP4K2C Activity and Impairs Focal Adhesion Formation in Galloway–Mowat Syndrome
    Article Snippet: .. Finally, the microarray was scanned using a microarray scanner (CapitalBio, Beijing, China). ..

    Article Title: Microarray Expression Profiling and Raman Spectroscopy Reveal Anti-Fatty Liver Action of Berberine in a Diet-Induced Larval Zebrafish Model
    Article Snippet: The Agilent zebrafish (V3) gene expression microarray 4×44K (Design ID 026437) was used for microarray analysis. .. The process of microarray scanning was carried out by CapitalBio Corporation (Beijing, China) as previously described ( ). ..

    Article Title: Identification of PDCD2 as a Candidate Target of Andrographolide That Arrests the Tumor Cell Cycle by Human Proteome-Scale Screening.
    Article Snippet: .. Finally, the samples were scanned by a microarray scanner (532 nm) (CapitalBio, Beijing, China). ..

    Article Title: One-step time-resolved cascade logic gate microfluidic chip for home testing of SARS-CoV-2 and flu B.
    Article Snippet: Home testing technology strategy is critical for early screening of disease.. However, current home testing technologies often require complex processes, which limits their application.. In this study, a time-resolved cascade logic gate microfluidic chip (TCLMC) was revealed to enable capillary force-based one-step operation without manual intervention or professional equipment.

    Gene Expression:

    Article Title: Chinese health biotech and the billion-patient market
    Article Snippet: Bio-Bridge Science , Exclusive out-license of papillomavirus pseudovirus technology to Loyola University (Chicago).. .. CapitalBio , Joint R&D and commercialization programs in China with Affymetrix (Santa Clara, CA, USA) for gene expression profiling and genotyping services (including the development of an advanced GeneChip-compatible point-of-care system) using Affymetrix's photolithographically synthesized oligonucleotide chip technology. Provided non-exclusive rights to Alpha Innotech (San Leandro, CA, USA) for marketing of CapitalBio's microarray laser scanner. Deal to undertake joint product development, manufacturing in China, technology transfer, services and products mutual representation with BioTools (Madrid). Deal to distribute Becton Dickinson (Franklin Lakes, NJ, USA) products in China. Exclusive rights to distribute certain products from Enzo Biochem (New York), BioMachines (Research Triangle Park, NC, USA), Aviva Systems Biology (San Diego), Macherey-Nagel (Düren, Germany), Advalytix (Brunnthal, Germany) in China. Exclusive rights to MediBic (Tokyo) to market CapitalBio's pharmacogenomic services in Japan. Exclusive rights to distribute certain CapitalBio products given to Greenmate Biotech (Seoul, Korea) in Korea, FK Biotec (Port Alegre, Brazil) in Brazil and VitroLab (Istanbul, Turkey) in Turkey. Nonexclusive distribution rights to certain CapitalBio products provided to TechnoConcept (New Delhi, India) and Viswagen Biotech (Kerala, India) in India and Australian Biosearch (Karrinyup, Australia) in Australia.. .. HD Biosciences , Codevelopment of functional assays for several identified GPCRs and ion channels with Organon. Under a nondisclosure agreement, undertaking assay development and hit-to-lead solution for GPCR and kinase targets with two major Western pharmaceutical companies. Cooperation agreement to develop GPCR screening models with Novasite Pharmaceuticals (San Diego)..

    Synthesized:

    Article Title: Chinese health biotech and the billion-patient market
    Article Snippet: Bio-Bridge Science , Exclusive out-license of papillomavirus pseudovirus technology to Loyola University (Chicago).. .. CapitalBio , Joint R&D and commercialization programs in China with Affymetrix (Santa Clara, CA, USA) for gene expression profiling and genotyping services (including the development of an advanced GeneChip-compatible point-of-care system) using Affymetrix's photolithographically synthesized oligonucleotide chip technology. Provided non-exclusive rights to Alpha Innotech (San Leandro, CA, USA) for marketing of CapitalBio's microarray laser scanner. Deal to undertake joint product development, manufacturing in China, technology transfer, services and products mutual representation with BioTools (Madrid). Deal to distribute Becton Dickinson (Franklin Lakes, NJ, USA) products in China. Exclusive rights to distribute certain products from Enzo Biochem (New York), BioMachines (Research Triangle Park, NC, USA), Aviva Systems Biology (San Diego), Macherey-Nagel (Düren, Germany), Advalytix (Brunnthal, Germany) in China. Exclusive rights to MediBic (Tokyo) to market CapitalBio's pharmacogenomic services in Japan. Exclusive rights to distribute certain CapitalBio products given to Greenmate Biotech (Seoul, Korea) in Korea, FK Biotec (Port Alegre, Brazil) in Brazil and VitroLab (Istanbul, Turkey) in Turkey. Nonexclusive distribution rights to certain CapitalBio products provided to TechnoConcept (New Delhi, India) and Viswagen Biotech (Kerala, India) in India and Australian Biosearch (Karrinyup, Australia) in Australia.. .. HD Biosciences , Codevelopment of functional assays for several identified GPCRs and ion channels with Organon. Under a nondisclosure agreement, undertaking assay development and hit-to-lead solution for GPCR and kinase targets with two major Western pharmaceutical companies. Cooperation agreement to develop GPCR screening models with Novasite Pharmaceuticals (San Diego)..

    Fluorescence:

    Article Title: One-step time-resolved cascade logic gate microfluidic chip for home testing of SARS-CoV-2 and flu B.
    Article Snippet: Home testing technology strategy is critical for early screening of disease.. However, current home testing technologies often require complex processes, which limits their application.. In this study, a time-resolved cascade logic gate microfluidic chip (TCLMC) was revealed to enable capillary force-based one-step operation without manual intervention or professional equipment.

    other:

    Article Title: Fluorescence microarrays for enzyme-free DNA detection based on web hybrid chain reaction
    Article Snippet: The DNA microarray were printed by Smart Arrayer (Beijing CapitalBio Co. Ltd.) and scanned by Luxsca-10K/A microarray Scanner (532 nm laser source for Cy3, Beijing CapitalBio Co. Ltd.).



    Similar Products

    dna microarray laser scanner (dna microarray scanner ba  (Agilent technologies)
    90
    Agilent technologies dna microarray laser scanner (dna microarray scanner ba
    <t>Microarray</t> analysis of transfected HeLa cells with miR-141 overexpressing vector. A Microarray analysis of gene expression in HeLa cells transfected with miR-141 overexpression vs. cells transfected with the control vector using a miRNA library from Exiqon. B Microarray analysis of gene expression in HeLa cells transfected with miR-141 overexpression vs. cells transfected with the control vector using oligonucleotides from Ambion. The blue color indicates the sustained gene expression, the red indicates the upregulated genes, and the green indicates the downregulated genes. C The expression of the most relevant genes to cervical cancer indicates the upregulated genes in red columns and downregulated genes in green. Error bars indicate the STD between Exiqon and Ambion data. D The potential binding sites of miR-141 within the 3 − UTR of KLRC1 and coding sequences of KLRC3, CAM3, and that carried out in-silico by miRWalk online tool
    Dna Microarray Laser Scanner (Dna Microarray Scanner Ba, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dna+microarray+laser+scanner+(dna+microarray+scanner+ba/pmc11370040-147-7-15
    Average 90 stars, based on 1 article reviews
    dna microarray laser scanner (dna microarray scanner ba - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Microarray analysis of transfected HeLa cells with miR-141 overexpressing vector. A Microarray analysis of gene expression in HeLa cells transfected with miR-141 overexpression vs. cells transfected with the control vector using a miRNA library from Exiqon. B Microarray analysis of gene expression in HeLa cells transfected with miR-141 overexpression vs. cells transfected with the control vector using oligonucleotides from Ambion. The blue color indicates the sustained gene expression, the red indicates the upregulated genes, and the green indicates the downregulated genes. C The expression of the most relevant genes to cervical cancer indicates the upregulated genes in red columns and downregulated genes in green. Error bars indicate the STD between Exiqon and Ambion data. D The potential binding sites of miR-141 within the 3 − UTR of KLRC1 and coding sequences of KLRC3, CAM3, and that carried out in-silico by miRWalk online tool

    Journal: BMC Cancer

    Article Title: Regulation of KLRC and Ceacam gene expression by miR-141 supports cell proliferation and metastasis in cervical cancer cells

    doi: 10.1186/s12885-024-12794-6

    Figure Lengend Snippet: Microarray analysis of transfected HeLa cells with miR-141 overexpressing vector. A Microarray analysis of gene expression in HeLa cells transfected with miR-141 overexpression vs. cells transfected with the control vector using a miRNA library from Exiqon. B Microarray analysis of gene expression in HeLa cells transfected with miR-141 overexpression vs. cells transfected with the control vector using oligonucleotides from Ambion. The blue color indicates the sustained gene expression, the red indicates the upregulated genes, and the green indicates the downregulated genes. C The expression of the most relevant genes to cervical cancer indicates the upregulated genes in red columns and downregulated genes in green. Error bars indicate the STD between Exiqon and Ambion data. D The potential binding sites of miR-141 within the 3 − UTR of KLRC1 and coding sequences of KLRC3, CAM3, and that carried out in-silico by miRWalk online tool

    Article Snippet: The microarray experiments were scanned using a DNA microarray laser scanner (DNA Microarray Scanner BA, Agilent Technologies) at 5 µm resolution using Ambion ship and Exiqon ship according to the manufacturer’s instructions.

    Techniques: Microarray, Transfection, Plasmid Preparation, Expressing, Over Expression, Control, Binding Assay, In Silico

    The prediction information between miR-141 and targeted genes identified by microarray analysis using in-silico miRWalk tool

    Journal: BMC Cancer

    Article Title: Regulation of KLRC and Ceacam gene expression by miR-141 supports cell proliferation and metastasis in cervical cancer cells

    doi: 10.1186/s12885-024-12794-6

    Figure Lengend Snippet: The prediction information between miR-141 and targeted genes identified by microarray analysis using in-silico miRWalk tool

    Article Snippet: The microarray experiments were scanned using a DNA microarray laser scanner (DNA Microarray Scanner BA, Agilent Technologies) at 5 µm resolution using Ambion ship and Exiqon ship according to the manufacturer’s instructions.

    Techniques: Microarray, Binding Assay